Authors:
PALTIEL O
RONEN I
POLLIACK A
ISCOVICH J
EPSTEIN L
Citation: O. Paltiel et al., THE CONTRIBUTION OF MULTIPLE DATA SOURCES TO A CLINICAL AUDIT OF LYMPHOMA IN A TEACHING HOSPITAL, International journal for quality in health care, 10(4), 1998, pp. 303-309
Citation: V. Barak et al., SOLUBLE IL-2 RECEPTOR AND BETA-2-MICROGLOBULIN LEVELS CORRELATE WITH DISEASE-ACTIVITY AND RESPONSE TO THERAPY IN LYMPHOMA AND CHRONIC LYMPHOCYTE LEUKEMIA, European cytokine network, 9(3), 1998, pp. 34-34
Authors:
BARAK V
NISMAN B
POLLIACK A
VANNIER E
DINARELLO CA
Citation: V. Barak et al., CORRELATION OF SERUM LEVELS OF INTERLEUKIN-1 FAMILY MEMBERS WITH DISEASE-ACTIVITY AND RESPONSE TO TREATMENT IN HAIRY-CELL LEUKEMIA, European cytokine network, 9(1), 1998, pp. 33-39
Authors:
STEINER H
POLLIACK A
KIMCHISARFATY C
LIBSTER D
FIBACH E
RUND D
Citation: H. Steiner et al., DIFFERENCES IN RHODAMINE-123 EFFLUX IN B-TYPE CHRONIC LYMPHOCYTIC-LEUKEMIA SUGGEST POSSIBLE GENDER AND STAGE VARIATIONS IN DRUG-RESISTANCE GENE ACTIVITY, Annals of hematology, 76(5), 1998, pp. 189-194
Citation: O. Paltiel et al., 2-WAY REFERRAL BIAS - EVIDENCE FROM A CLINICAL AUDIT OF LYMPHOMA IN ATEACHING HOSPITAL, Journal of clinical epidemiology, 51(2), 1998, pp. 93-98
Authors:
LOSSES IS
BOGOMOLSKIYAHALOME V
YEHUDA O
BENNERIAH S
BENYEHUDA D
LEIZEROWITZ R
POLLIACK A
Citation: Is. Losses et al., A NOVEL TRANSLOCATION (1-2)(P34-P21-22) IN ACUTE MYELOMONOBLASTIC LEUKEMIA, Cancer genetics and cytogenetics, 106(1), 1998, pp. 78-79
Citation: R. Or et al., FLUDARABINE MONOPHOSPHATE AS THERAPY FOR MURINE LEUKEMIA MODIFIES GRAFT-VERSUS-HOST DISEASE (GVHD) WITHOUT DECREASING THE GRAFT-VERSUS-LEUKEMIA (GVL) EFFECT, British Journal of Haematology, 102(1), 1998, pp. 64-64
Authors:
ISCOVICH J
PALTIEL O
AZIZI E
KUTEN A
GAT A
LIFZCHITZMERCER B
ZLOTOGORSKI A
POLLIACK A
Citation: J. Iscovich et al., CUTANEOUS LYMPHOMA IN ISRAEL, 1985-1993 - A POPULATION-BASED INCIDENCE STUDY, British Journal of Cancer, 77(1), 1998, pp. 170-173
Citation: A. Polliack, HAIRY-CELL LEUKEMIA AND ALLIED CHRONIC LYMPHOID LEUKEMIAS - CURRENT KNOWLEDGE AND NEW THERAPEUTIC OPTIONS, Leukemia & lymphoma, 26, 1997, pp. 41-51
Authors:
SHUBINSKY G
SCHLESINGER M
POLLIACK A
RABINOWITZ R
Citation: G. Shubinsky et al., PATHWAYS CONTROLLING THE EXPRESSION OF SURFACE CD21 (CR-2) AND CD23 (FC(EPSILON)IIR) PROTEINS IN HUMAN-MALIGNANT B-CELLS, Leukemia & lymphoma, 25(5-6), 1997, pp. 521-530
Authors:
RUND D
BENNERIAH S
YEHUDA O
LEIZEROWITZ R
OKON E
POLLIACK A
Citation: D. Rund et al., DE-NOVO ACUTE MYELOID-LEUKEMIA WITH NEAR-PENTAPLOIDY - DIPLOID KARYOTYPE AND LYMPHOBLASTIC PHENOTYPE AT RELAPSE, Leukemia & lymphoma, 25(5-6), 1997, pp. 585-591
Authors:
LOSSOS IS
OKON E
BOGOMOLSKIYAHALOM V
RON N
POLLIACK A
Citation: Is. Lossos et al., SINUS HISTIOCYTOSIS WITH MASSIVE LYMPHADENOPATHY (ROSAI-DORFMAN DISEASE) - REPORT OF A PATIENT WITH ISOLATED RENOTESTICULAR INVOLVEMENT AFTER CURE OF NON-HODGKINS-LYMPHOMA, Annals of hematology, 74(1), 1997, pp. 41-44
Citation: Ys. Haviv et al., LYMPHOMA AND SYSTEMIC-SCLEROSIS - AN UNCOMMON ASSOCIATION OR POSSIBLECOINCIDENCE OF 2 DISORDERS WITH A FATAL OUTCOME, European journal of haematology, 59(3), 1997, pp. 194-196
Citation: A. Polliack et al., SWEAT ANALYSIS FOLLOWING PRESSURE ISCHEMIA IN A GROUP OF DEBILITATED SUBJECTS, Journal of rehabilitation research and development, 34(3), 1997, pp. 303-308
Authors:
KAHAN E
IBRAHIM AS
ELNAJJAR K
RON E
ALAGHA H
POLLIACK A
ELBOLKAINY MN
Citation: E. Kahan et al., CANCER PATTERNS IN THE MIDDLE-EAST - SPECIAL REPORT FROM THE MIDDLE-EAST-CANCER-SOCIETY, Acta oncologica, 36(6), 1997, pp. 631-636
Citation: S. Bulvik et A. Polliack, SEVERE RESISTANT IMMUNE THROMBOCYTOPENIC PURPURA (ITP) COMPLICATING CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) RESPONDING TO A COMBINATION OF FLUDARABINE AND DANAZOL, Blood, 90(10), 1997, pp. 3076-3076
Citation: H. Steiner et al., GENDER DIFFERENCES IN MULTIDRUG-RESISTANCE GENE-1 (MDR1) EXPRESSION IN LOW-GRADE, B-CELL TYPE NONHODGKINS-LYMPHOMA (NHL), Blood, 90(10), 1997, pp. 3659-3659
Citation: S. Gillis et A. Polliack, 8 YEAR FOLLOW-UP OF 15 PATIENTS WITH REFRACTORY CLL, AND LOW-GRADE LYMPHOMA RESPONDING TO FLUDARABINE AS SINGLE-AGENT SALVAGE THERAPY, Blood, 90(10), 1997, pp. 4129-4129
Citation: I. Lossos et A. Polliack, COMBINATION OF FLUDARABINE AND CYCLOPHOSPHAMIDE - A POTENTIALLY USEFUL SALVAGE REGIMEN FOR REFRACTORY OR RELAPSING SMALL AND LARGE-CELL LYMPHOMA, Blood, 90(10), 1997, pp. 860-860
Citation: R. Or et al., FLUDARABINE MONOPHOSPHATE REDUCES THE INCIDENCE AND SEVERITY OF GRAFT-VERSUS-HOST DISEASE IN A MURINE MODEL OF BONE-MARROW TRANSPLANTATION, Blood, 90(1), 1997, pp. 471-471
Authors:
ZEIDMAN A
FLORU S
ROBINSON A
POLLIACK A
DJALDETI M
SAVIR H
MITTELMAN M
Citation: A. Zeidman et al., PANUVEITIS RESPONSIVE TO 2-CDA - AN UNUSUAL OCULAR PRESENTATION OF HAIRY-CELL LEUKEMIA, Leukemia & lymphoma, 20(5-6), 1996, pp. 501-503
Authors:
BENYEHUDA D
POLLIACK A
OKON E
SHERMAN Y
FIELDS S
LEBENSHART P
LOTAN H
LIBSON E
Citation: D. Benyehuda et al., IMAGE-GUIDED CORE-NEEDLE BIOPSY IN MALIGNANT-LYMPHOMA - EXPERIENCE WITH 100 PATIENTS THAT SUGGESTS THE TECHNIQUE IS RELIABLE, Journal of clinical oncology, 14(9), 1996, pp. 2431-2434